Hawaii Legislature Moves to Terminate Tenured Professor

Carl-Wilhelm Vogel could lose his position at the University of Hawai‘i Cancer Center if the currently proposed state budget is signed by Governor David Ige.

Written byLisa Winter
| 2 min read
Stock image, close up of a man's hand, holding a pen and signing a contract.

Register for free to listen to this article
Listen with Speechify
0:00
2:00
Share

ABOVE: © ISTOCK.COM, ROBERT DALY

The fate of an academic’s job is generally decided by the institution, but Carl-Wilhelm Vogel, a tenured professor at the University of Hawai‘i at Mānoa, could lose his position after more than 20 years at the institution because the state’s legislature has singled out his $343,800 salary as something to cut in this year’s proposed budget.

“In addition to teaching zero classes [and] bringing in zero dollars, he doesn’t hold office hours,” State Senator Donna Kim (D-14), chairperson of the higher education committee, tells Hawaii News Now (HNN) in defense of the line item. The University of Hawai‘i Cancer Center (UHCC) where Vogel works is a research institution that does not offer classes, which is why he does not teach or hold office hours, reports Inside Higher Ed.

Vogel joined UHCC as its director in 1999, holding the position until 2008, Inside Higher Ed reports. ...

Interested in reading more?

Become a Member of

The Scientist Logo
Receive full access to more than 35 years of archives, as well as TS Digest, digital editions of The Scientist, feature stories, and much more!
Already a member? Login Here

Related Topics

Meet the Author

  • Lisa joined The Scientist in 2017. As social media editor, some of her duties include creating content, managing interactions, and developing strategies for the brand’s social media presence. She also contributes to the News & Opinion section of the website. Lisa holds a degree in Biological Sciences with a concentration in genetics, cell, and developmental biology from Arizona State University and has worked in science communication since 2012.

    View Full Profile
Share
February 2026

A Stubborn Gene, a Failed Experiment, and a New Path

When experiments refuse to cooperate, you try again and again. For Rafael Najmanovich, the setbacks ultimately pushed him in a new direction.

View this Issue
Human-Relevant In Vitro Models Enable Predictive Drug Discovery

Advancing Drug Discovery with Complex Human In Vitro Models

Stemcell Technologies
Redefining Immunology Through Advanced Technologies

Redefining Immunology Through Advanced Technologies

Ensuring Regulatory Compliance in AAV Manufacturing with Analytical Ultracentrifugation

Ensuring Regulatory Compliance in AAV Manufacturing with Analytical Ultracentrifugation

Beckman Coulter Logo
Conceptual multicolored vector image of cancer research, depicting various biomedical approaches to cancer therapy

Maximizing Cancer Research Model Systems

bioxcell

Products

Sino Biological Logo

Sino Biological Pioneers Life Sciences Innovation with High-Quality Bioreagents on Inside Business Today with Bill and Guiliana Rancic

Sino Biological Logo

Sino Biological Expands Research Reagent Portfolio to Support Global Nipah Virus Vaccine and Diagnostic Development

Beckman Coulter

Beckman Coulter Life Sciences Partners with Automata to Accelerate AI-Ready Laboratory Automation

Refeyn logo

Refeyn named in the Sunday Times 100 Tech list of the UK’s fastest-growing technology companies